Venous thromboembolism and mortality in patients with hematological malignancies
{{output}}
Mortality and venous thromboembolism (VTE) are major risks for patients with hematological malignancies. However, they are commonly underrepresented in major clinical trials of VTE. Treatment decisions are further complicated by the unique characteristics they... ...
